JNBA Financial Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.4M Sell
27,701
-567
-2% -$54.3K 0.2% 62
2025
Q4
$2.72M Sell
28,268
-159
-0.6% -$15.4K 0.24% 57
2025
Q3
$2.71M Sell
28,427
-1,279
-4% -$118K 0.25% 52
2025
Q2
$2.59M Buy
29,706
+1,146
+4% +$97.2K 0.25% 55
2025
Q1
$2.57M Sell
28,560
-4
-0% -$358 0.27% 49
2024
Q4
$2.28M Sell
28,564
-24
-0.1% -$2.08K 0.23% 54
2024
Q3
$2.57M Buy
28,588
+480
+2% +$40.4K 0.26% 51
2024
Q2
$2.21M Sell
28,108
-501
-2% -$41.1K 0.23% 59
2024
Q1
$2.49M Sell
28,609
-351
-1% -$30K 0.26% 53
2023
Q4
$2.39M Buy
28,960
+252
+0.9% +$19.2K 0.27% 59
2023
Q3
$2.25M Buy
28,708
+11
+0% +$921 0.28% 58
2023
Q2
$2.53M Buy
28,697
+82
+0.3% +$7.06K 0.3% 58
2023
Q1
$2.31M Sell
28,615
-80
-0.3% -$6.52K 0.3% 60
2022
Q4
$2.23M Sell
28,695
-1,161
-4% -$94.1K 0.31% 59
2022
Q3
$2.41M Buy
29,856
+174
+0.6% +$15.6K 0.37% 54
2022
Q2
$2.66M Sell
29,682
-3,422
-10% -$347K 0.4% 50
2022
Q1
$3.67M Sell
33,104
-665
-2% -$70.3K 0.49% 46
2021
Q4
$3.49M Sell
33,769
-42
-0.1% -$4.86K 0.43% 46
2021
Q3
$4.24M Sell
33,811
-25
-0.1% -$3.24K 0.57% 42
2021
Q2
$4.2M Sell
33,836
-687
-2% -$86.3K 0.57% 44
2021
Q1
$4.08M Buy
34,523
+759
+2% +$89K 0.59% 44
2020
Q4
$3.96M Sell
33,764
-5,782
-15% -$637K 0.65% 40
2020
Q3
$4.11M Sell
39,546
-2,191
-5% -$220K 0.83% 32
2020
Q2
$3.83M Sell
41,737
-883
-2% -$84.7K 0.82% 30
2020
Q1
$3.84M Sell
42,620
-650
-2% -$69.2K 0.92% 31
2019
Q4
$4.91M Sell
43,270
-188
-0.4% -$20.6K 0.94% 30
2019
Q3
$4.72M Buy
43,458
+657
+2% +$68.5K 0.96% 26
2019
Q2
$4.17M Buy
42,801
+856
+2% +$78.2K 0.85% 25
2019
Q1
$3.82M Sell
41,945
-517
-1% -$46.3K 0.82% 26
2018
Q4
$3.86M Buy
42,462
+40,012
+1,633% +$3.74M 0.88% 23
2018
Q3
$241K Sell
2,450
-41,447
-94% -$3.83M 0.11% 113
2018
Q2
$3.76M Hold
43,897
0.79% 23
2018
Q1
$3.52M Sell
43,897
-1,650
-4% -$136K 0.75% 23
2017
Q4
$3.68M Hold
45,547
0.77% 21
2017
Q3
$3.54M Sell
45,547
-135
-0.3% -$11.2K 0.79% 22
2017
Q2
$4.05M Sell
45,682
-1,365
-3% -$115K 0.92% 19
2017
Q1
$3.79M Buy
47,047
+200
+0.4% +$15.6K 0.89% 19
2016
Q4
$3.34M Buy
46,847
+42,273
+924% +$3.32M 0.81% 20
2016
Q3
$395K Sell
4,574
-41,465
-90% -$3.61M 0.06% 120
2016
Q2
$4M Sell
46,039
-2,534
-5% -$205K 1.12% 18
2016
Q1
$3.64M Sell
48,573
-2,200
-4% -$166K 1.31% 17
2015
Q4
$3.9M Sell
50,773
-292
-0.6% -$22K 1.5% 15
2015
Q3
$3.42M Sell
51,065
-4,974
-9% -$366K 1.46% 15
2015
Q2
$4.15M Sell
56,039
-3,906
-7% -$298K 1.57% 12
2015
Q1
$4.67M Sell
59,945
-719
-1% -$54.5K 1.8% 12
2014
Q4
$4.38M Sell
60,664
-4,204
-6% -$292K 1.76% 12
2014
Q3
$4.02M Sell
64,868
-28
-0% -$1.78K 1.82% 12
2014
Q2
$4.14M Sell
64,896
-700
-1% -$42.5K 2.01% 13
2014
Q1
$4.04M Buy
65,596
+150
+0.2% +$8.74K 2.13% 12
2013
Q4
$3.76M Sell
65,446
-820
-1% -$46.5K 2.06% 12
2013
Q3
$3.53M Hold
66,266
2.2% 12
2013
Q2
$3.41M Buy
+66,266
New +$3.28M 2.34% 11

Other funds holding MDT

JNBA Financial Advisors's MDT Position: Q1 2026 in Review

JNBA Financial Advisors reduced its Medtronic (MDT) stake by 2% in Q1 2026, selling an estimated $54.3K and leaving 27,701 shares worth $2.4M. The position accounts for 0.2% of the portfolio, ranked #62.

JNBA Financial Advisors first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.91M in Q4 2019. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • JNBA Financial Advisors held 27,701 shares of Medtronic worth $2.4M as of Q1 2026.
  • JNBA Financial Advisors sold 567 Medtronic shares in Q1 2026, an estimated $54.3K.
  • Medtronic made up 0.2% of JNBA Financial Advisors's portfolio in Q1 2026, its #62 holding.
  • JNBA Financial Advisors first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • JNBA Financial Advisors's Medtronic position peaked at $4.91M in Q4 2019.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on JNBA Financial Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.